Improvement of renal function in type 2 diabetic nephropathy

Renal Failure

Volumn 29, Issue 2, 2007, Pages 155-158

  Futrakul, Narisa ^a   Butthep, Punnee ^b   Futrakul, Prasit ^a   Sitprija, Visith ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Circulating endothelial cell; Diabetic nephropathy; FE Mg; Hemodynamic maladjustment; Vasodilators; VEGF

Indexed keywords

MAGNESIUM; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; ARTERIOLE; ARTICLE; BLOOD VESSEL FUNCTION; CAPILLARY FLOW; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EARLY DIAGNOSIS; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY TUBULE FUNCTION; MAGNESIUM EXCRETION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS;

ADULT; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATOR AGENTS;

EID: 33847202536     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220601095835     Document Type: Article

References (17)

1. Amos AF, McCarthy DJ, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet. Med. 1997;14(Suppl. 5):S1-S85.
2. Parving HH, Hommel E, Mathiesen E, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br. Med. J. 1988;296:156-160.
3. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 1997;99:342-348.
4. Moriya T, Moriya R, Yajima Y, et al. Urinary albumin as an indicator of diabetic nephropathy lesions in Japanese type 2 diabetic patients. Nephron. 2002;91:292-299.
5. Risdon FC, Sloper SA, de Wardener HE. Relationship between renal function and histologic changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet. 1968;2:363-366.
6. Futrakul P, Yenrudi S, Futrakul N, Sensirivatana R, Kingwatanakul P, Jungthirapanich J, et al. Tubular function and tubulointerstitial disease. Am. J. Kidney Dis. 1999;33:886-891.
7. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 2002;13:806-816.
8. Futrakul N, Yenrudi S, Sensirivatana R, Watana D, Laohapaibul A, Watanapenphaibul K, et al. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren. Fail. 2000;22:329-335.
9. Fine LG, Ong ACM, Norman JT. Mechanism of tubulointerstitial injury in progressive renal disease. Eur. J. Clin. Invest. 1993;25:259-265.
10. Butthep P, Nuchprayoon I, Futrakul N. Endothelial injury and altered hemodynamics in Thalassemia. Clin. Hemorheol. Microcirc. 2004;31:287-293.
11. Futrakul N, Sitprija V, Siriviriyakul P, Futrakul P. Glomerular endothelial dysfunction, altered hemorheology and hemodynamic maladjustment in nephrosis with focal segmental glomerulosclerosis. Hong Kong J. Nephrol. 2004;6:69-73.
12. Futrakul N, Laohaphaibul A, Futrakul P. Glomerular endothelial dysfunction and hemodynamic maladjustment in vesicoureteric reflux. Ren. Fail. 2003;25:479-483.
13. Futrakul P, Pochanugool C, Poshyachinda M, et al. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: therapeutic benefit with vasodilators. J. Med. Assoc. Thai. 1992;75:375-385.
14. Pisoni R, Faraone R, Ruggenenti P, Remuzzi G. Inhibitors of the rennin angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency. J. Neprhol. 2002;15:428-430.
15. Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, et al. In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR. J. Am. Soc. Nephrol. 1999;10:997-1006.
16. Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetes rats. J. Am. Soc. Nephrol. 2005;16:703-711.
17. Hilgers, K. Never too early to treat type 2 DN. J. Am. Soc. Nephrol. 2005;16:574-575.